Global Medical REIT Inc.
NYSE: GMRE · REAL ESTATE · REIT - HEALTHCARE FACILITIES
Updated 2026-02-20
Global Medical REIT Inc. (GMRE) Stock Valuation Analysis
Fair value estimate, historical valuation range, and quality signals for GMRE.
Valued
Valuation reasonably reflects current fundamentals. Limited margin of safety at these levels.
GMRE historical valuation range
Where current P/E sits in GMRE's own 5Y range.
GMRE intrinsic value (DCF)
DCF-based fair value estimate vs current market price.
Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.
GMRE valuation signals
Quick-read green flags, caution flags, and risks based on current metrics.
P/E Ratio — History
P/S Ratio — History
Current: 6.77x
Is GMRE overvalued in 2026?
Global Medical REIT Inc. (GMRE) currently trades at $35.98 per share with a market capitalization of $979,776,000.00. Based on our multi-factor framework, the stock trades at a fair valuation with a Smart Value Score of 52/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.
GMRE currently has no meaningful P/E ratio, which typically signals that the company is unprofitable, near breakeven, or emerging from a loss-making period. With a P/S ratio of 6.8x, the market is valuing the company primarily on its revenue rather than its earnings.
Our discounted cash flow model estimates GMRE's intrinsic value at $48.68 per share, against the current market price of $35.98. This implies a margin of safety of +24.51%. A meaningful cushion exists against model error, making this a reasonable risk-adjusted entry.
The Piotroski F-Score of 4/9 puts financial quality in a middling range, neither a standout strength nor an obvious red flag.
Bottom line: GMRE trades at a fair valuation on our framework, with a Smart Value Score of 52/100. The valuation is defensible but offers no obvious bargain. Patience or a better entry price may reward disciplined buyers.
Frequently asked questions
Is GMRE overvalued?
GMRE scores 52/100 on our Smart Value Score (Grade C), a mixed overall profile. The DCF also shows a positive margin of safety, so price and fundamentals line up reasonably well.
What is GMRE's fair value?
Our DCF model estimates GMRE's intrinsic value at $48.68 per share, versus the current price of $35.98, a margin of safety of +24.51%. Fair value is the present value of the cash flows we project the business to produce, so a price below it means the market is pricing the stock below that conservative estimate.
What P/E ratio does GMRE trade at?
GMRE does not have a meaningful P/E right now, usually a sign of unprofitability or an earnings transition. For unprofitable growth names, price-to-sales is the more useful gauge.
Is GMRE a buy based on valuation?
Our Smart Value rating for GMRE is Hold, from a Smart Value Score of 52/100 that blends growth, quality, and valuation. The profile is balanced and best suited to investors who already have a thesis. This is research to inform your decision, not personalized financial advice.
How does GMRE's valuation compare to its history?
There is not enough historical valuation data yet for a confident percentile read on GMRE.
What is GMRE's Smart Value Score?
GMRE's Smart Value Score is 52/100. It is a proprietary WallStSmart metric blending growth quality, financial health, and valuation into a single 0-100 read, and scores above 75 are rare, signaling strong multi-factor alignment.